Effects of plasmapheresis on mycophenolic acid concentrations

Transplantation

Volumn 91, Issue 1, 2011, Pages

  Maldonado, Angela Q ^a,b   Davies, Neal M ^c   Crow, Stacy A ^a   Little, Cindy ^d   Ojogho, Okechukwu N ^b   Weeks, Douglas L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b SACRED HEART MEDICAL CENTER   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Inland Northwest Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SERUM ALBUMIN;

ADULT; AGED; BLOOD VOLUME; CASE REPORT; CENTRIFUGATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; ERYTHROCYTE; EVENING DOSAGE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMATOCRIT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MORNING DOSAGE; MYASTHENIA GRAVIS; PLASMA VOLUME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN BINDING;

FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYASTHENIA GRAVIS; MYCOPHENOLIC ACID; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 78751671776     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fc0a35     Document Type: Letter

References (5)

1. Ibrahim RB, Liu C, Cronin SM, et al. Drug removal by plasmapheresis: An evidencebased review. Pharmacotherapy 2007;27:1529.
2. Jacobsen P, Long J, Rogosheske J, et al. High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction. Biol Blood Marrow Transplant 2005;11:977.
3. Mudge DW, Atcheson BA, Taylor PJ, et al. Severe toxicity associated withamarkedly elevated mycophenolic acid free fraction in a renal transplant recipient. Ther Drug Monit 2004;26:453.
4. Sam WJ, Akhlaghi F, Rosenbaum SE. Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients. J Clin Pharmacol 2009;49:185.
5. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 2007;46:13.